“The deal reflects our continued focus on essential healthcare real estate supported by institutional-quality operators in high-growth markets. Depending upon the level of risk and patient characteristics, evidence-based options include ezetimibe and/or bempedoic acid (a newer oral agent) or a PCSK9 monoclonal antibody, an injectable therapy. Lipid-lowering therapy includes statins and other newer treatments in […]